Cargando…
COL3A1: Potential prognostic predictor for head and neck cancer based on immune‐microenvironment alternative splicing
We aimed to identify a novel prognostic biomarker for head and neck squamous cell carcinoma (HNSCC) based on tumor immunology‐related alternative splicing (AS). Data for 502 HNSCC and 44 normal samples were obtained from the TCGA database and used to establish an AS‐related risk model through univar...
Autores principales: | Shen, Yuchen, Li, Xinyu, Wang, Deming, Zhang, Liming, Li, Xiao, Su, Lixin, Fan, Xindong, Yang, Xitao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972170/ https://www.ncbi.nlm.nih.gov/pubmed/36039012 http://dx.doi.org/10.1002/cam4.5170 |
Ejemplares similares
-
Novel prognostic model established for patients with head and neck squamous cell carcinoma based on pyroptosis-related genes
por: Shen, Yuchen, et al.
Publicado: (2021) -
Construction of the prognostic signature of alternative splicing revealed the prognostic predictor and immune microenvironment in head and neck squamous cell carcinoma
por: Ye, Fan, et al.
Publicado: (2022) -
Systematic analysis of survival‐associated alternative splicing signatures uncovers prognostic predictors for head and neck cancer
por: Liang, Ying, et al.
Publicado: (2019) -
Prognostic role of alternative splicing events in head and neck squamous cell carcinoma
por: Ding, Yanni, et al.
Publicado: (2020) -
Identification and validation of an alternative splicing-based prognostic signature for head and neck squamous cell carcinoma
por: Zhao, Xinyuan, et al.
Publicado: (2020)